Objectives: Direct gene transfer of exogenous nitric oxide synthase, with the subsequent increase in nitric oxide production, could represent a potential therapeutic strategy in the treatment of vascular proliferative disorders. The goal of the present study was to determine if porcine coronary arteries could be transduced with an adenoviral vector encoding endothelial nitric oxide synthase Ž . Ad.CMVeNOS resulting in functional expression. Methods and Results: Segments of porcine right coronary artery were exposed for 1 Ž
. h at 378C to either replication-deficient adenovirus encoding bovine endothelial nitric oxide synthase Ad.CMVeNOS, 5 = 10 pfurml Ž
9
. or control adenovirus encoding Escherichia coli b-galactosidase Ad.CMVLacZ, 5 = 10 pfurml . Immunohistochemistry with a Ž . monoclonal antibody specific for nitric oxide synthase NOS demonstrated recombinant gene expression in both the endothelial and adventitial layers of Ad.CMVeNOS transduced coronaries with only endogenous NOS confirmed in the endothelium of Ad.CMVLacZ Ž . arteries. Coronary arteries transduced with Ad.CMVeNOS yielded 517 " 110 mean " S.E.M. nMrng nitrite while vessels transduced Ž . with Ad.CMVLacZ yielded 126 " 84 nMrng P -0.05, n s 6 . Isometric tension recording, following prostaglandin F constriction, 2 a Ž documented a reduced tension in Ad.CMVeNOS transduced coronaries, compared to matched Ad.CMVLacZ coronaries 6.10 " 1.08 g . . arginine L-NMMA, 10 M . The EC for calcium ionophore relaxation of Ad.CMVeNOS coronary arteries was reduced compared to 50 Ž . Ad.CMVLacZ y7.90 " 0.03 logM vs. y7.26 " 0.11 logM, respectively, P -0.05, n s 8 . Conclusions: These studies demonstrate successful transfer of endothelial nitric oxide synthase into porcine coronary arteries as verified by histochemical localization of recombinant protein with an increase of nitric oxide release as demonstrated by enhanced nitrite production and an alteration in vasomotor function. q 1997 Elsevier Science B.V.
Introduction w x
Three different genes encoding endothelial 1,2 , neuw x w x ronal 3,4 , and macrophage nitric oxide synthase 5, 6 have been cloned, illustrating that diverse processes such as vascular signaling, neurotransmission in the brain and cell-mediated toxicity are dependent on the production of nitric oxide. In the cardiovascular system, nitric oxide is a potent vasodilator and plays a key role in the modulation Ž . of vascular tone. In addition, nitric oxide: a inhibits Ž . smooth muscle cell proliferation and migration, b inhibits Ž . platelet aggregation, c inhibits leukocyte adhesion, and Ž . w x d scavenges superoxide anions 7-10 .
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0008-6363r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved. Successful direct gene transfer of the endothelial nitric oxide synthase gene into injured rat carotid arteries has been demonstrated to increase vasomotor relaxation and w x inhibit intimal hyperplasia 11 . These results suggest that direct gene transfer with subsequent increase in nitric oxide production could represent a potential therapeutic strategy in the treatment of cardiovascular disease. However, the rat carotid injury model has limitations as a model of human vascular proliferative diseases such as coronary restenosis following revascularization procedures. Coronary arteries of pigs respond to vascular injury analow x gous to humans 12 . We therefore have proceeded with the development of adenoviral gene transfer into porcine coronary arteries to study the biological effects of recombinant nitric oxide synthase expression.
The purpose of the present investigation was to demonstrate the functional expression of recombinant nitric oxide synthase in porcine coronary arteries. plaque forming unitsrml in diluted MEM for 60 min at 378C. The arterial segments were then transferred to fresh medium 199 and incubated for 48 h at 378C in a 5% CO 2 Ž . incubator Forma Scientific, Inc., Marietta, OH .
Methods

Procedures
Histochemistry
Histochemical staining of vessels for b-galactosidase activity was initiated with fixation of segments in 2% paraformaldehyder0.2% glutaraldehyde in phosphate Ž . buffered saline PBS for 30 min. The vessels were rinsed twice with PBS and placed in 5-bromo-4-chloro-3-indolyl-Ž . b-D-galactopyranoside X-Gal reagent at 378C for 1.5-4 h, the staining was terminated by return to fixation solution w x prior to nonspecific staining of control specimens 18 . Vessels were then dehydrated through graded alcohol to xylene washes and, subsequently, embedded in paraffin. Serial, 5 mm every 50 mm, sections were counterstained with eosin.
Immunohistochemical staining of vessels for eNOS ex-Ž . pression was initiated with flash freezing y708C of Ž artery segments in O.C.T. compound Miles, Inc., Elkhart, . IN . Serial, 5 mm every 50 mm, sections were obtained Ž . and immersed in acetone 48C and 1% paraformaldehyderEDTA. The sections were then incubated in 0.1% sodium azider0.3% hydrogen peroxide and incubated in 5% goat serumrPBS-Tween 20 to complex non-specific Ž protein binding locales. An eNOS monoclonal antibody 5 mgrml, 1 : 50 dilution, Transduction Laboratory, Lexing- . ton, KY was applied for 60 min at room temperature, followed by incubations with biotinylated rabbit anti-mouse Ž X . Ž . F ab 2 1 : 300, 20 min secondary antibody and peroxi-Ž dase-conjugated streptavidin 1 : 300, 20 min, Vector Lab-. oratories, Burlingame, CA . Immunoreactivity of eNOS was documented by 3-amino-9-ethylcarbazole and hematoxylin counterstaining following 0.1 molrl sodium ac-Ž . etate buffer pH 5.2 immersion for 30 s. The specificity of eNOS immunolabelling was controlled by omission of primary anti-goat antiserum in the incubation medium in random sections.
Measurement of nitrite production
Nitrite measurements were made from 1 ml aliquots of Krebs' buffer with 10 y4 M L-arginine and 10 y6 M calcium ionophore A23187 in which coronary arteries transduced with either Ad.CMVeNOS or Ad.CMVLacZ were incubated for 2 h at 378C. Nitrite production was measured w x using a spectrofluorometric assay 19 . This technique is based upon the chemical reaction of 2,3-diaminoaphtha-Ž . lene DAN with nitrite which, under acidic conditions, Ž . yields the fluorescent product 1-H -naphthotriazole. One Ž hundred microliters of freshly prepared DAN 0.05 mgrml . in 0.62 M HCl was added to 1 ml of sample. After a 10 min incubation at 208C, the reaction was terminated with 50 ml of 2.8 N NaOH. The addition of base maximized the fluorescent signal produced by the product. Sodium nitrite standards are made fresh in Type I H O. The intensity of 2 fluorescence was measured in a System 3 Scanning Spec-Ž . trofluorometer Farrand Optical Co., Vahalla, NY with excitation at 365 nm and emission at 450 nm using a 1.5 ml disposable polystyrene cuvette.
Endothelium-dependent relaxations to calcium ionophore A23187
Segments of transduced coronary segments were evalu-Ž . ated in parallel in organ chambers 25 
Drugs
The drugs, L-arginine, L-NMMA, indomethacin, prostaglandin F , and calcium ionophore A23187, were ob- 
Statistical analysis
Results are expressed as mean " standard error of the Ž . mean S.E.M. . In all experiments, 'n' refers to the number of porcine coronary arterial segments taken. Only paired segments, treated with either Ad.CMVeNOS or Ad.CMVLacZ, are reported herein. Statistical evaluation of data was performed with Student's t-test for paired Ž . observations. Two-tailed analysis of variance ANOVA with post-hoc Newman-Keuls was performed on the dose-response curves to calcium ionophore. Values were considered to be statistically significant when P -0.05.
Results
Localization of reporter gene
Following 48 h of ex vivo incubation, segments of porcine coronary arteries were stained en face for b-Ž . galactosidase activity in every experiment n s 14 . Luminal and adventitial staining was noted in coronaries transduced with Ad.CMVLacZ only, no b-galactosidase staining was noted in paired coronaries transduced with Ž . Ad. CMVeNOS Fig. 1A and B . Histochemical analysis of these sections confirmed localization of recombinant bgalactosidase activity in luminal endothelial cells and ad-Ž . ventitial fibroblasts Fig. 1C and D in Ad.CMVLacZ coronaries.
Localization of nitric oxide synthase
Transduced coronary arteries were also subject to immunohistochemical staining with a monoclonal antibody 
Nitrite production of porcine coronary arteries
Porcine coronary arteries were stimulated for 2 h with L-arginine and calcium ionophore at 378C and total nitrite production was determined by spectrofluorometric analysis. Coronaries transduced with Ad.CMVLacZ yielded 126 Ž . "84 nM nitritermg protein n s 6 while Ad.CMVeNOS transduced coronaries yielded 517 " 110 nM nitritermg Ž . protein Fig. 2 . 10 M , prostaglandin F constriction produced equivalent tension was 2 a Ž . developed in Ad.CMVeNOS and Ad.CMVLacZ coronaries Ž8.08 " 2.03 g vs. 9.40 " 2.46 g, respectively, P s NS, . n s 6 . Porcine coronary arteries transduced with Ad.CMVeNOS demonstrated augmented relaxation to increasing concentrations of calcium ionophore in the pres-Ž . ence of indomethacin Fig. 3A . The concentration of calcium ionophore required to generate a relaxation equivalent to 50% maximum, EC , was calculated to be 7.90 " 
Isometric tension recordings of Õasomotor function
M attenuated calcium ionophore-Ž . mediated relaxations Fig. 3B . 
Discussion
This investigation of porcine coronary arteries demon-Ž . strates 1 expression of recombinant genes as demonstrated by augmented immunohistochemical staining of NOS but absent histochemical staining of b-galactosidase Ž . Ž . activity, 2 enhanced nitrite production, 3 augmented response to increased calcium ionophore concentrations, Ž . and 4 attenuation of calcium ionophore-induced relaxations with competitive inhibition of nitric oxide synthase.
The demonstration of transgene expression by a monoclonal antibody specific for NOS is complicated by the constitutive nature of endogenous NOS in the coronary artery. Indeed, endothelial expression of NOS was documented in the porcine coronary arteries transduced with Ad.CMVLacZ. In light of the NOS expression present in both the endothelium and adventitia of Ad.CMVeNOS transduced coronaries, treated identically exclusive of the viral vector utilized, it is seductive to attribute the entirety of the adventitial localization of NOS in these coronaries to transgene expression. However, the selective recruitment of inducible NOS within Ad.CMVeNOS must be addressed. The complexity of isoform expression of NOS is only now reaching clarity. Indeed, constitutive expres-Ž . sion of iNOS type II has been demonstrated in certain w x cell lines and tissues 24,25 . This is in contrast to the majority of the literature which documents iNOS only in w x response to cytokines or lipopolysaccharide 26-28 . Transcriptional elements receptive to cytokines, NF-kBrRel, have been demonstrated upstream iNOS, both in animals w x and humans 29, 30 . In confirmation of the constitutive expression of iNOS, low levels of iNOS promoter activity have been demonstrated in human tissue in the absence of w x cytokine stimulation 30 . Nonetheless, since cytokines are freely diffusible with the vascular wall, the selective expression of NOS within the endothelium and adventitia, but not the media, could be singularly interpreted as Ž . transgene and eNOS type III expression. Furthermore, the vector, at the viral titer utilized in the current investigation, has previously been demonstrated not to generate w x cytotoxicity or functional iNOS activity 31 .
Further evidence of transgene expression is provided by analysis of stimulated nitrite production in transduced coronaries; Ad.CMVeNOS transduced coronary arteries generated fivefold more nitrite than Ad.CMVLacZ transduced arterial segments. Porcine coronary arteries transduced with Ad.CMVeNOS produced less tension with prostaglandin F than matched arteries transduced with 2 a Ad.CMVLacZ, a differential effect eliminated by a competitive inhibitor of NOS, L-NMMA. The EC for cal-50 cium ionophore, in the presence of cyclooxygenase inhibition, was reduced by Ad.CMVeNOS transduction. In review, though each methodology to document augmentation of the nitric oxide synthase pathway by Ad.CMVeNOS transduction has specific limitations, the combined consensus of the present investigation clearly suggests recombinant nitric oxide synthase expression and, subsequent, function.
The presented results are in conformity with those w x reports by van der Leyen and colleagues 11 . The expression of recombinant eNOS in rat carotid arteries reduced KCl evoked contractions. The current investigation has been extrapolated to the coronary circulation of an animal model well characterized to the human coronary circulation.
Nitric oxide synthase was chosen as an candidate for adenoviral directed gene therapy as nitric oxide is capable of inhibiting platelet aggregation, smooth muscle proliferation, and leukocyte adhesion, in addition to serving as a superoxide scavenger. Though these actions of nitric oxide were not specifically addressed in the current ex vivo investigation, we have shown our adenoviral vector encoding for bovine endothelial nitric oxide synthase is capable of augmenting nitric oxide production in the coronary circulation.
Impairment of endothelial-dependent response to platelets, and the subsequent production of nitric oxide, has been demonstrated 4 weeks following endothelial dew x nudement in a porcine model 32 . Similarly, in a canine model of coronary reperfusion injury, it has been demonstrated that endothelium-dependent relaxation to receptordependent agonists was significantly impaired through Gprotein dysfunction and impaired generation of nitric oxide w x 33 . Reperfusion injury and subsequent oxygen radical endothelial injury has also been demonstrated to inhibit receptor-dependent release of nitric oxide and lead to w x endothelial dysfunction 34 . Clearly, augmentation of nitric oxide production by adenoviral-mediated transgene expression within these clinical scenarios would impart a degree of normalcy. The demonstration of beneficial action with this therapeutic intention will be the subject of future investigation.
These studies define the biological function of an adenoviral vector in an ex vivo porcine coronary model. Techniques for endovascular coronary delivery are continuing to be refined, including systems which yield efficient adventitial delivery with a transvascular injection catheter w x 35 . Alternatively, the coronary circulation is available for prolonged periods of time during surgical procedures. In our model, combined adventitial and luminal expression of recombinant Ad.CMVeNOS has led to beneficial biological responses and will merit further in vivo studies to define its therapeutic role in the treatment of vasculoproliferative diseases such as restenosis after percutaneous coronary angioplasty.
In conclusion, the present study demonstrates adenoviral-mediated expression of eNOS in porcine coronary ar- teries resulting in enhanced immuno-reactivity, nitrite production, and relaxation to agonists of NOS.
